Home・Listă Acțiuni・Ocugen Inc

Ocugen Inc

Închisă

1.02 0.99

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

0.99

Maxim

1.04

Indicatori cheie
By Trading Economics
Venit	-5.7M -25M
Vânzări	-45K 1.5M
EPS	-0.07
Marjă de profit	-1,671.841
Angajați	116
EBITDA	-2.5M -20M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+920% upside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-67M 349M
Deschiderea anterioară	0.03
Închiderea anterioară	1.02

Ocugen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 oct. 2026, 23:56 UTC

Little change in after-market trading, modest gains and losses.

1 oct. 2026, 23:56 UTC

Correlated Moves

Public Service Enterprise Group Inc declined in after-market trading, remaining below its 20-day moving average and near the lower end of its one-month range.

1 oct. 2026, 23:56 UTC

Camtek Ltd experienced a modest decline during after-market hours on Thursday, following a session that closed roughly flat.

1 oct. 2026, 23:55 UTC

Aramark is trading modestly lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

1 oct. 2026, 23:55 UTC

Elevance Health Inc is trading higher in after-market hours, maintaining gains following a peak earlier in the session despite recent lower closes.

1 oct. 2026, 23:55 UTC

Xenon Pharmaceuticals Inc declined in after-market trading, moving lower since Thursday's close and remaining significantly below its 20-day moving average.

1 oct. 2026, 23:55 UTC

Biogen Inc is trading modestly higher in after-market hours, maintaining a position above its 20-day moving average and near its one-month range.

1 oct. 2026, 23:55 UTC

Beyondspring Inc is experiencing a notable decline in after-market trading, having fallen significantly since Thursday's close despite being above its 20-day moving average.

1 oct. 2026, 23:51 UTC

Mastercraft Boat Holdings Inc is trading modestly lower in after-market hours, slipping below Thursday's close and remaining significantly below its 20-day moving average.

1 oct. 2026, 23:51 UTC

CF Industries Holdings Inc is trading modestly lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

1 oct. 2026, 23:51 UTC

Weyerhaeuser Co advanced in after-market trading, recovering from earlier lows to reach its highest level since Thursday's close, despite recent weakness.

1 oct. 2026, 23:51 UTC

Macy's Inc is declining in after-market trading, following a modest lower close on Thursday, and is near the low end of today's trading range.

1 oct. 2026, 23:51 UTC

Correlated Moves

IDEX Corp's shares rose in after-market trading, continuing a positive trend since Thursday, influenced by Lincoln Electric's slight increase and broader market gains.

1 oct. 2026, 23:51 UTC

Allegion PLC is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

1 oct. 2026, 23:51 UTC

Correlated Moves

Macro News

The USD/CAD is trading lower as rising bond yields and geopolitical tensions impact energy markets, despite maintaining a position above its 20-day moving average.

1 oct. 2026, 23:51 UTC

KeyCorp's shares are declining in after-market trading, marking the lowest point of the day after an initial gain and continuing a trend of lower finishes.

1 oct. 2026, 23:51 UTC

Mexico's Inflation Rate Expected to Decrease Slightly to 3.87% Amid Optimism for Economic Growth and Stable Interest Rates

1 oct. 2026, 23:51 UTC

Mexico's Inflation Rate Expected to Drop Slightly as Economic Growth Projections Improve Ahead of October 8 Release.

1 oct. 2026, 23:51 UTC

Japan's August unemployment rate rises to 2.5%, exceeding forecasts and raising concerns amid inflationary pressures.

1 oct. 2026, 23:51 UTC

South Korea's September inflation rate holds steady at 2.9%, matching forecasts but signaling potential easing pressures on future monetary policy amid mixed economic signals.

1 oct. 2026, 23:51 UTC

U.S. Factory Orders Report on October 2 Forecasts Modest Growth Amid Mixed Manufacturing Sentiment and Ongoing Economic Pressures

1 oct. 2026, 23:50 UTC

Aquestive Therapeutics Inc has advanced in after-market trading following three consecutive sessions of declines, though the price remains below its 20-day moving average.

1 oct. 2026, 23:50 UTC

CorMedix Inc saw a significant increase in after-market trading, recovering from a low point to reach a peak return, despite being below its 20-day moving average.

1 oct. 2026, 23:50 UTC

Ecolab Inc declined in after-market trading, retracing sharply from a brief peak and remaining below its 20-day moving average.

1 oct. 2026, 23:50 UTC

Accuray Inc's shares fell in after-market trading, marking a fourth consecutive session of declines amid challenging conditions for health care equipment stocks.

1 oct. 2026, 23:50 UTC

Endava PLC has advanced in after-market trading, reaching its highest cumulative return since Thursday's close following earlier volatility.

1 oct. 2026, 23:50 UTC

W.P. Carey Inc. is declining in after-market trading, continuing a trend of three consecutive lower daily closes and remaining below its 20-day moving average.

1 oct. 2026, 23:46 UTC

Lemonade Inc is trading slightly lower in after-hours action, having retraced from a peak earlier in the session and positioned below its 20-day moving average.

1 oct. 2026, 23:46 UTC

Social Media

In after-market trading, Corning Inc shares have advanced slightly, supported by a new $3 billion deal with AT&T and analysts eyeing a breakout above $161.50.

1 oct. 2026, 23:45 UTC

Mid-America Apartment Communities Inc is trading higher in after-market hours, following earlier gains, but remains below its 20-day moving average.

Comparație

Modificare preț

Ocugen Inc Așteptări

Obiectiv de preț

By TipRanks

920% sus

Prognoză pe 12 luni

Medie 10.2 USD 920%

Maxim 12 USD

Minim 8 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcugen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor Ocugen Inc - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.